Ser522
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.4
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser522  -  BMAL1 (mouse)

Site Information
IRGSsPssCGSSPLN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1878257206

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 ) , mutation of modification site ( 1 )
Disease tissue studied:
neuroblastoma ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
CAMK2D (human) ( 1 )
Treatments:
ISX-9 ( 1 )

Downstream Regulation
Effects of modification on BMAL1:
activity, induced ( 1 )
Effects of modification on biological processes:
transcription, induced ( 1 )

References 

1

Li H, et al. (2022) ISX-9 potentiates CaMKII╬┤-mediated BMAL1 activation to enhance circadian amplitude. Commun Biol 5, 750
35902736   Curated Info